<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">73021</article-id><article-id pub-id-type="doi">10.7554/eLife.73021</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>TREM2 regulates purinergic receptor-mediated calcium signaling and motility in human iPSC-derived microglia</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-250513"><name><surname>Jairaman</surname><given-names>Amit</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5206-700X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-250530"><name><surname>McQuade</surname><given-names>Amanda</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-250531"><name><surname>Granzotto</surname><given-names>Alberto</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-250534"><name><surname>Kang</surname><given-names>You Jung</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-250535"><name><surname>Chadarevian</surname><given-names>Jean Paul</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-250532"><name><surname>Gandhi</surname><given-names>Sunil</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-9"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-86302"><name><surname>Parker</surname><given-names>Ian</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-83888"><name><surname>Smith</surname><given-names>Ian</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9910-195X</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-250533"><name><surname>Cho</surname><given-names>Hansang</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-194793"><name><surname>Sensi</surname><given-names>Stefano L</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-99402"><name><surname>Othy</surname><given-names>Shivashankar</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6832-5547</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-166747"><name><surname>Blurton-Jones</surname><given-names>Mathew</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" corresp="yes" id="author-15953"><name><surname>Cahalan</surname><given-names>Michael D</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4987-2526</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Physiology and Biophysics</institution>, <institution>University of California</institution>, <addr-line><named-content content-type="city">Irvine</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Neurobiology and Behavior</institution>, <institution>University of California, Irvine</institution>, <addr-line><named-content content-type="city">Irvine</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Mechanical Engineering and Engineering Science</institution>, <institution>University of North Carolina</institution>, <addr-line><named-content content-type="city">Charlotte</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Physiology and Biophysics</institution>, <institution>University of California, Irvine</institution>, <addr-line><named-content content-type="city">Irvine</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Department of Neuroscience, Imaging and Clinical Sciences</institution>, <institution>University G d'Annunzio of Chieti-Pescara</institution>, <addr-line><named-content content-type="city">Chieti</named-content></addr-line>, <country>Italy</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-38503"><name><surname>Prakriya</surname><given-names>Murali</given-names></name><role>Reviewing editor</role><aff><institution>Northwestern University</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>mblurton@uci.edu</email> (MB);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>mcahalan@uci.edu</email> (MC);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>22</day><month>02</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e73021</elocation-id><history><date date-type="received"><day>13</day><month>08</month><year>2021</year></date><date date-type="accepted"><day>18</day><month>02</month><year>2022</year></date></history><permissions><copyright-statement>Â© 2022, Jairaman et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Jairaman et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-73021-v1.pdf"/><abstract><p>The membrane protein TREM2 (Triggering Receptor Expressed on Myeloid cells 2) regulates key microglial functions including phagocytosis and chemotaxis. Loss-of-function variants of TREM2 are associated with increased risk of Alzheimer's disease (AD). Because abnormalities in Ca<sup>2+</sup> signaling have been observed in several AD models, we investigated TREM2 regulation of Ca<sup>2+</sup> signaling in human induced pluripotent stem cell-derived microglia (iPSC-microglia) with genetic deletion of TREM2. We found that iPSC-microglia lacking TREM2 (TREM2 KO) show exaggerated Ca<sup>2+</sup> signals in response to purinergic agonists, such as ADP, that shape microglial injury responses. This ADP hypersensitivity, driven by increased expression of P2Y<sub>12</sub> and P2Y<sub>13</sub> receptors, results in greater release of Ca<sup>2+</sup> from the endoplasmic reticulum (ER) stores, which triggers sustained Ca<sup>2+</sup> influx through Orai channels and alters cell motility in TREM2 KO microglia. Using iPSC-microglia expressing the genetically encoded Ca<sup>2+</sup> probe, Salsa6f, we found that cytosolic Ca<sup>2+</sup> tunes motility to a greater extent in TREM2 KO microglia. Despite showing greater overall displacement, TREM2 KO microglia exhibit reduced directional chemotaxis along ADP gradients. Accordingly, the chemotactic defect in TREM2 KO microglia was rescued by reducing cytosolic Ca<sup>2+</sup> using a P2Y<sub>12</sub> receptor antagonist. Our results show that loss of TREM2 confers a defect in microglial Ca<sup>2+</sup> response to purinergic signals, suggesting a window of Ca<sup>2+</sup> signaling for optimal microglial motility.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 NS14609</award-id><principal-award-recipient><name><surname>Cahalan</surname><given-names>Michael D</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 AI121945</award-id><principal-award-recipient><name><surname>Cahalan</surname><given-names>Michael D</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 AG048099</award-id><principal-award-recipient><name><surname>Blurton-Jones</surname><given-names>Mathew</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 AG056303</award-id><principal-award-recipient><name><surname>Blurton-Jones</surname><given-names>Mathew</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 AG055524</award-id><principal-award-recipient><name><surname>Blurton-Jones</surname><given-names>Mathew</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>core AG066519</award-id><principal-award-recipient><name><surname>Blurton-Jones</surname><given-names>Mathew</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>U01 AI160397</award-id><principal-award-recipient><name><surname>Othy</surname><given-names>Shivashankar</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>T32 NS082174</award-id><principal-award-recipient><name><surname>McQuade</surname><given-names>Amanda</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>RF1DA048813</award-id><principal-award-recipient><name><surname>Gandhi</surname><given-names>Sunil</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Sunil Gandhi, is a co-founders of NovoGlia Inc..</p></fn><fn fn-type="conflict" id="conf3"><p>Mathew Blurton-Jones, is a co-inventor of patent application WO/2018/160496, related to the differentiation of pluripotent stem cells into microglia. Is a co-founders of NovoGlia Inc..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Human iPSC lines were generated by the University of California Alzheimer's Disease Research Center (UCI ADRC) stem cell core. Subject fibroblasts were collected under approved Institutional Review Boards (IRB) and human Stem Cell Research Oversight (hSCRO) committee protocols. Informed consent was received for all participants.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>RNA sequencing data referenced in Figure 1- figure supplement 2 is available through Gene Expression Omnibus: GSE157652.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>McQuade A et al</collab></person-group><year iso-8601-date="2020">2020</year><source>Transcriptomic and functional deficits in human TREM2-/- microglia impair response to Alzheimer's pathology in vivo [RNA-seq]</source><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE157652">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE157652</ext-link><comment>NCBI Gene Expression Omnibus, GSE157652</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-73021-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>